Covid-19: Results from India's 12 molnupiravir clinical trials remain unpublished.
作者信息
Mahase Elisabeth
机构信息
The BMJ.
出版信息
BMJ. 2022 Aug 19;378:o2063. doi: 10.1136/bmj.o2063.
PMID:35985657
Abstract
摘要
相似文献
1
Covid-19: Results from India's 12 molnupiravir clinical trials remain unpublished.新冠疫情：印度12项莫努匹拉韦临床试验的结果仍未公布。
BMJ. 2022 Aug 19;378:o2063. doi: 10.1136/bmj.o2063.
2
Molnupiravir: A new candidate for COVID-19 treatment.莫努匹韦：COVID-19 治疗的新候选药物。
Pharmacol Res Perspect. 2022 Feb;10(1):e00909. doi: 10.1002/prp2.909.
3
Molnupiravir for treatment of COVID-19.莫努匹韦用于治疗新型冠状病毒肺炎。
Med Lett Drugs Ther. 2022 Jan 24;64(1642):10-11.
4
Comment on: Molnupiravir for the treatment of non-severe COVID-19: a systematic review and meta-analysis of 14 randomized trials with 34 570 patients.评论：莫努匹拉韦治疗非重症新型冠状病毒肺炎：对14项随机试验（涉及34570名患者）的系统评价和荟萃分析
J Antimicrob Chemother. 2024 Jul 1;79(7):1717-1718. doi: 10.1093/jac/dkae124.
5
Molnupiravir for the Treatment of Coronavirus Disease 2019: A Systematic Review With Meta-Analysis of 12,451 Patients.莫努匹拉韦治疗冠状病毒病2019：对12451例患者的系统评价与荟萃分析
Am J Ther. 2024;31(1):e47-e50. doi: 10.1097/MJT.0000000000001541. Epub 2022 Jul 20.
6
RdRp inhibitors and COVID-19: Is molnupiravir a good option?RdRp 抑制剂与 COVID-19：莫那比拉韦是一个好选择吗？
Biomed Pharmacother. 2022 Feb;146:112517. doi: 10.1016/j.biopha.2021.112517. Epub 2021 Dec 9.
7
Discovery, Development, and Patent Trends on Molnupiravir: A Prospective Oral Treatment for COVID-19.莫努匹韦的发现、研发与专利趋势：一种有前景的 COVID-19 口服治疗药物
Molecules. 2021 Sep 24;26(19):5795. doi: 10.3390/molecules26195795.
8
Molnupiravir in unvaccinated patients with COVID-19.莫努匹韦在未接种疫苗的 COVID-19 患者中的应用。
Drug Ther Bull. 2022 Mar;60(3):35. doi: 10.1136/dtb.2022.000002. Epub 2022 Jan 31.
9
Molnupiravir in COVID-19: A systematic review of literature.莫努匹韦治疗 COVID-19：文献系统评价。
Diabetes Metab Syndr. 2021 Nov-Dec;15(6):102329. doi: 10.1016/j.dsx.2021.102329. Epub 2021 Oct 30.
10
An updated practical guideline on use of molnupiravir and comparison with agents having emergency use authorization for treatment of COVID-19.关于莫努匹韦的使用的最新实用指南，以及与具有治疗 COVID-19 的紧急使用授权的药物的比较。
Diabetes Metab Syndr. 2022 Feb;16(2):102396. doi: 10.1016/j.dsx.2022.102396. Epub 2022 Jan 13.
引用本文的文献
1
Effectiveness of Molnupiravir and Nirmatrelvir-Ritonavir in Hospitalized Patients With COVID-19 : A Target Trial Emulation Study.莫努匹韦和奈玛特韦-利托那韦在 COVID-19 住院患者中的疗效：一项目标试验模拟研究。
Ann Intern Med. 2023 Apr;176(4):505-514. doi: 10.7326/M22-3057. Epub 2023 Mar 14.
Zotero 插件